Addus HomeCare Director Gets 1,172 Restricted Shares – Insider Filing
Addus HomeCare (NASDAQ:ADUS) filed a Form 4 reporting that non-employee director Esteban Lopez received 1,172 restricted shares of common stock on 06/18/2025 at no cost.
Rhea-AI Filing Summary
Addus HomeCare (NASDAQ:ADUS) filed a Form 4 reporting that non-employee director Esteban Lopez received 1,172 restricted shares of common stock on 06/18/2025 at no cost. The grant will vest in full on 06/18/2026. Following the award, Lopez directly owns 4,538 shares of ADUS. No sales, options exercises, or cash transactions were disclosed.
This filing reflects routine board equity compensation and does not signal any change in the company’s financial condition, operations, or strategic direction.
Positive
- None.
Negative
- None.
Insights
Routine director stock grant; neutral for valuation
The Form 4 shows a standard annual equity award of 1,172 restricted shares to director Esteban Lopez, increasing his stake to 4,538 shares. The absence of sales or large value transfers points to ordinary-course compensation rather than an insider view on near-term share performance. There are no red flags regarding Rule 10b5-1 usage or unusual timing. As such, the disclosure is immaterial to current investors beyond standard transparency requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,172 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.
FAQ
What is Esteban Lopez’s total beneficial ownership after the reported transaction?
Did the Form 4 disclose any sale of Addus HomeCare stock?
Why did Addus HomeCare file this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.